Buscar
Mostrando ítems 1-10 de 468
Monoclonal Antibody for Patients with Covid-19
(Massachusetts Medical Society, 2021-03-25)
The ACTIV-3/TICO LY-CoV555 Study Group (Dec. 22)1 hypothesized that low penetration of the antibody into the infected lungs might explain the lack of benefit of bamlanivimab (LY-CoV555) in hospitalized patients with ...
Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
(Dove Medical Press Ltd, 2017-01-01)
Colorectal cancer is considered a disease of the elderly population. Since the number of geriatric patients continues to rise, monoclonal antibody therapy is the most promising therapy in the recent research. Presently, ...
Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis
(Expert Reviews, 2008-07-01)
This review discusses some of the impacts that biotechnology, genomics and nanotechnology convergence should have on future cancer management, in particular, the development of innovative diagnostic and therapeutic approaches ...
Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors
(2017-04-03)
The usual treatments for patients with non-small-cell lung cancer (NSCLC), such as advanced lung adenocarcinoma, are unspecific and aggressive, and include lung resection, radiotherapy and chemotherapy. Recently, treatment ...
Immunotherapy For The Treatment Of Colorectal Tumors: Focus On Approved And In-clinical-trial Monoclonal Antibodies
(Dove Medical Press LtdAlbany, 2017)
Monoclonal antibodies carried in drug delivery nanosystems as a strategy for cancer treatment
(2021-01-01)
Monoclonal antibodies carried in nanosystems have been extensively studied and reported as a promising tool for the treatment of various types of cancers. Monoclonal antibodies have great advantages for the treatment of ...
Biosimilar monoclonal antibodies in Latin America
(IntechOpen, 2021)
Antibodies, also known as immunoglobulins, are complex glycoproteins produced by B-cells against foreign substances as part of the adaptive immune response [1, 2]. The invention of the hybridoma technology in 1975 by Köhler ...
Monoclonal Antibody Therapeutics As Potential Interferences On Protein Electrophoresis And Immunofixation
(WALTER DE GRUYTER GMBHBERLIN, 2016)
Targeted Therapies For The Treatment Of Non-small-cell Lung Cancer: Monoclonal Antibodies And Biological Inhibitors
(Taylor & Francis IncPhiladelphia, 2017)
Terapias biológicas en el lupus eritematoso sistémico
(Sociedad Médica de Santiago, 2010)